Conclusion and Overview
A note on method. This report sorts its content into four categories wherever possible: facts (from company disclosures and live market data), assumptions (valuation parameters, maintenance capex, and the like), inferences (calculations and conclusions built on the facts), and opinions (the final investment judgment). Unless stated otherwise, all amounts are in US dollars. The current price uses the latest available US market data: CRS last traded at about $487.25, for a market cap of roughly $24.51 billion.
1. The conclusion, up front
| Item | Judgment |
|---|---|
| Investment rating | Watch |
| Is there a margin of safety at the current price | No |
| Suitable investor type | Cyclical-quality investors and deep industry researchers; not suitable for ordinary long-term investors looking for a "conservative value spread" |
| How understandable is the business | 4/5 |
| Industry attractiveness | 3/5 |
| Moat strength | 3.5/5 |
| Management and capital allocation | 3.5/5 |
The core judgment. Carpenter Technology is not a hard business to understand: at its heart it sells high-performance specialty alloys and process solutions, serving aerospace, defense, and other settings where the cost of material failure is extremely high. Businesses like this naturally enjoy certification barriers, customer stickiness, and a degree of pricing power. The company's operating quality has improved markedly over the past two years, especially in the Specialty Alloys Operations (SAO) segment, where product mix, price realization, and operating efficiency are all trending up. In FY2025 adjusted free cash flow reached $287.5 million, and for FY2026 management raised its operating-income guidance to $700 million to $705 million and its adjusted free-cash-flow guidance to roughly $350 million. The problem is that these strengths are already fully, even excessively, priced in: at the latest price, CRS trades at roughly 51x earnings, about 60x TTM free cash flow, about 31.5x EV/EBITDA, and about 11.9x book value. For a capital-intensive, highly cyclical specialty-materials company still exposed to the rhythm of the aerospace supply chain, those are very demanding valuations.
The one-line version. This is a specialty-materials company that increasingly resembles a high-quality cyclical leader, but at today's price it is better described as a good company at a bad price, rather than a long-term acquisition target with a margin of safety.
The biggest uncertainties. First, how much of SAO's current high margins is a structural upgrade versus a windfall from the aerospace and defense super-cycle. Second, whether the new supply from brownfield expansion, once it comes online, will erode the industry's current supply-demand gap and pricing environment. Third, the valuation the market assigns today embeds a very high and very durable cash-flow growth requirement; if the aerospace chain, medical destocking, or the raw-material and working-capital cadence falls short, the drawdown could be permanent rather than merely a "fluctuation."
The Business, the Industry, and the Moat
2. Understanding the business: how does this company actually make money?
Carpenter Technology's core activity is producing and delivering high-performance specialty alloys and related process solutions. The company has two operating segments: SAO (the specialty-alloys core) and PEP (Performance Engineered Products, which includes Dynamet titanium, Additive, and some distribution business). In FY2025 SAO generated sales of $2,563.6 million and PEP generated $405.4 million; SAO operating income was $588.6 million, while PEP managed only $37.0 million. That tells you the true center of value today is heavily concentrated in SAO and its high-end aerospace and defense materials capabilities.
By end market, of the company's total FY2025 sales of $2,877.1 million, aerospace and defense contributed $1,768.6 million, or about 61%; medical was $351.2 million, energy $200.3 million, with the remainder in transportation, industrial and consumer, and distribution. By the third fiscal quarter of FY2026, measured on a net-sales-excluding-surcharge basis, aerospace and defense had reached 66% of the quarter. In other words, the company increasingly looks like an "aerospace and defense specialty-materials" name rather than a balanced, diversified metals conglomerate.
It charges not through subscriptions or platform take-rates, but through very traditional industrial-goods logic: selling materials, selling processing capability, and selling certified, highly reliable delivery. A meaningful part of revenue is raw-material surcharge revenue; the company discloses that it uses surcharges, index mechanisms, base-price adjustments, and raw-material forward contracts to buffer price swings in nickel, cobalt, titanium, and other key inputs. Put differently, Carpenter does not make money by "betting on raw-material direction," but mainly through materials design, certification, product mix, process yield, customer relationships, and capacity-utilization efficiency.
The "repeatability" of this business sits between consumer staples and commodity cyclicals. It does not generate highly predictable subscription revenue, yet neither is it purely one-off order flow: in demanding applications such as aircraft engines, fasteners, structural parts, medical implants, and energy equipment, once a material specification, certification, quality record, and supply-chain qualification are established, orders tend to persist for many years. In FY2026 Q3 the company specifically noted double-digit improvement in aerospace structural sub-market orders, with long-term agreements strengthening order visibility and price consistency. At the same time, the company openly acknowledges that the business is seasonal and cyclical, and that demand in aerospace, defense, and energy can all swing significantly.
On cost structure, this is a classic capital-intensive manufacturer. Raw-material price swings, melting/forging/finishing capacity, labor and maintenance, and the cash tied up in inventory all matter a great deal. The company discloses that roughly 40% of net sales come from firm-price arrangements, leaving gross-margin volatility risk when raw-material prices swing sharply; FY2025 repair and maintenance expense was $128.6 million, FY2025 capex was $154.3 million, capex in the first nine months of FY2026 already reached $157.6 million, and full-year capex is expected to hit $260 million. So this is not an asset-light model, and not a company that "gets lighter as it grows."
On dependence, the good news is that no single customer accounts for more than 10% of sales, and no single customer accounts for more than 10% of receivables. The bad news is that its dependence on the aerospace and defense cycle, key raw-material supply, the cadence of customer certifications, and the reliability of manufacturing equipment is very high. In its own risk disclosures, the company explicitly states that the business is affected by aerospace, defense, and energy market cycles, by the price and availability of key raw materials, and by issues at key aerospace participants such as Boeing.
If I treated this enterprise as a private company to hold without looking at the share price for five years, my answer would be: the business itself is ownable, but only at a reasonable purchase price. From a long-term owner's standpoint, I would happily own a low-leverage aerospace specialty-materials leader with high certification barriers and improving cash flow; but I would not acquire this business at anything like today's price.
Business understandability score: 4/5. It is not a complex financial or internet platform, but because of surcharges, LIFO, capital intensity, cyclicality, and granular material specifications, understanding it takes some ability to cut through industrial-manufacturing and accounting noise.
3. Industry and competitive landscape
This industry looks more like high-barrier cyclical manufacturing than the low-capital-intensity, linear-demand, brand-driven industries Buffett most favors. Long-term demand is fine: commercial-fleet maintenance and replacement, engine upgrades, defense modernization, medical implants, and energy equipment all need reliable materials. But the short and medium term are quite cyclical, driven by build rates, inventory restocking, oil-and-gas conditions, and supply-chain swings. In its own risk disclosures the company lists aerospace, defense, and energy as end markets that have historically been cyclical.
The competitive landscape is not crowded. In its 10-K the company states explicitly that for its high-value, demanding products, "fewer than ten companies" make up its main competitors, and that many products can only be supplied after passing complex customer specifications and qualifications. The company also emphasizes that its more than 135 years of metallurgical and manufacturing experience, its technical capability, its product mix, and its R&D investment form entry barriers. That statement matters: it tells you this is not commodity steel where "anyone with a mill can do it," but a niche with barriers of certification, yield, metallurgical know-how, and track record.
But the industry is hardly a sit-back-and-collect paradise. First, industry profitability depends heavily on capacity structure, product structure, and the supply-demand gap. Second, the price and availability of raw materials (nickel, cobalt, chromium, titanium, and so on) affect profitability through inventory, surcharge lag, and hedging. Third, even though customers face high certification barriers, substitution risk is not absent: material substitution, process substitution, customer destocking, and OEM output swings can all change near- and medium-term earnings.
So my characterization of the industry is: not "a great company in a great industry," but closer to "an increasingly excellent company in an above-average industry." To be even stricter, it still carries some of the "good company in a bad industry" character, except that as aerospace and defense rise as a share of the mix, the company's business quality is improving. In FY2026 Q3 management described the current environment directly as an accelerating demand environment, especially in aerospace and defense, and judged that the supply-demand gap is still widening. That judgment may well be correct, but it also implies that current earnings may still carry a cyclical premium.
Industry attractiveness score: 3/5. Long-term demand is decent and barriers are high, but capital intensity, raw-material volatility, and end-market cyclicality are pronounced.
4. Moat analysis
Carpenter's moat is not network effects or data; its weightiest source is materials qualification, process know-how, a track record in critical applications, and relationship-based long-term agreements. The brand means nothing in mass markets, but in aircraft engines, fasteners, structural parts, medical, and energy, the "brand" is really embodied as a trusted source of materials and a record of meeting specifications. The company explicitly notes that many high-value products must first pass complex customer specifications, and that its technical capability, product mix, and R&D efforts are competitive barriers.
On cost advantage, I would not score it highly. The company is certainly improving productivity, product mix, and operating efficiency, and the rapid margin improvement in SAO from FY2025 to FY2026 proves its execution; but it is not the kind of resource-advantaged, naturally lowest-cost producer. More precisely, its advantage lies in prioritizing limited capacity toward more complex, higher-value materials, rather than crushing rivals on absolute cost. In FY2026 Q3 the company repeatedly attributed margin expansion to mix upgrade, price realization, and productivity gains, rather than simple scale dilution.
Scale advantages and switching costs exist, but they are not invincible. A new entrant trying to replicate this must face investment in melting, forging, and finishing equipment, materials development and validation, customer qualification, and the accumulation of a quality record, which typically takes years and substantial capital; this conclusion is an inference, based on the company's disclosures about "fewer than ten major competitors" and about needing to pass complex customer certification before supplying. By contrast, network effects and data advantages can essentially be treated as absent. Patents have value, but the company itself states explicitly that it does not rely on any single patent or group of patents, so patents are not the most central source of the moat.
On the direction of the moat, my judgment is that SAO is widening while PEP is more divided. SAO is benefiting from a rising aerospace and defense share, the advance of long-term agreements, customers' greater sensitivity to supply security, and the capacity released by brownfield expansion; PEP, by contrast, went through consecutive Additive adjustments and distribution-related impairments in FY2024–2025, and in FY2026 Q3 it remained clearly weaker than SAO. In other words, this is not a company where "everything is strong," but more one where "the core business is strong while the peripheral businesses still have to prove themselves."
In an inflationary environment, the company has some pricing power. On raw materials it relies on surcharges, index mechanisms, and forward purchase contracts; at the base-profit level, management has explicitly emphasized over recent quarters that base price realization, mix improvement, and pricing actions are continuing. But I must stress that pricing power is not the same as recession resistance: the company still posted operating losses in FY2021 and FY2022, proving that while it is better than the average metals manufacturer, it is far from the kind of Kweichow Moutai-style moat that earns steadily even through downturns.
Moat strength score: 3.5/5. The moat is real, but it is closer to a certification-and-process barrier than to a super-monopoly structure that earns reliably regardless of the cycle.
Management and Capital Allocation
5. Is management trustworthy, and is capital allocation rational?
The conclusion first: over the past two to three years, management's operating execution and capital allocation have clearly been a positive, though not yet to the point of an unconditionally high score. In the FY2026 Q3 earnings call and presentation materials, the company laid out its capital-allocation framework clearly: repurchasing stock and maintaining the dividend on one side, advancing brownfield expansion on the other, while keeping healthy liquidity and low net leverage. As of March 31, 2026, liquidity was about $793.8 million, including $294.8 million of cash and $499.0 million of available revolving credit; net debt to EBITDA was about 0.5x. For a cyclical manufacturer, that balance sheet is a clear strength.
Three things about capital allocation deserve particular credit. First, the sequence is sensible: deleverage first, then expand, then buy back. In November 2025 the company issued $700 million of 5.625% senior unsecured notes due 2034, while redeeming its old 6.375% notes due 2028 and 7.625% notes due 2030; although this produced a $15.6 million loss on debt extinguishment, the subsequent interest burden is lighter and the maturity profile is cleaner. Second, the dividend has been steady in recent years, with $30.2 million paid in the first nine months of FY2026. Third, buybacks have advanced in step with improving profits and cash flow, rather than being forced through under high leverage to prop up earnings per share.
In the third fiscal quarter of FY2026, the company repurchased 14.5 thousand shares? in the quarter — more precisely, 145 thousand shares, for $52.7 million; over the first nine months it repurchased a cumulative 445 thousand shares for $133.9 million, at an average repurchase price of about $301 per share, well below the current market price of roughly $487 per share. From a long-term shareholder's perspective, this is a positive: at least so far, buybacks have not been done at the most frenzied moments.
But the reasons "not to buy" and "not to award a high score" must also be made clear. First, historically the company has not been a flawless allocator. In FY2024 it took a $14.1 million goodwill impairment on Latrobe Distribution and also recorded restructuring and asset impairments at Carpenter Additive; that shows peripheral-business allocation, post-acquisition integration, and new-business experimentation do not always create value. Second, from 2021 to 2025 year-end shares outstanding did not shrink meaningfully but actually rose from about 48.04 million to about 49.71 million, an increase of roughly 3.5% over five years; in other words, the recent buybacks look more like a company "starting to step on the gas" than a per-share value compounding machine built up over many years. Third, judging from the official materials directly available, management ownership reflects a professional-manager stake-and-incentive structure rather than founder-style large ownership; the precise percentage needs further verification against the complete tables in the latest proxy statement.
On candor, I give management an above-average mark. The company has not papered over the Additive problems; on the contrary, it has consecutively disclosed restructuring, impairments, and improvement progress, and it has not dodged discussion of commercial-aerospace, raw-material, medical-destocking, and customer build-rate risks. For a cyclical manufacturer, the habit of "putting bad news into the financials" and "separately itemizing special items" deserves credit.
Management and capital allocation score: 3.5/5. Clearly rational and well-executed in recent years, but with a less-than-flawless history and still some distance from the master-class capital-allocation record of "every dollar deployed at a high return."
Financial Quality and Owner Earnings
6. Financial quality analysis
Start with the five-year throughline: Carpenter has moved from the FY2021–FY2022 trough to a strong recovery in FY2024–FY2026. FY2021 revenue was $1,475.6 million, with an operating loss of $248.6 million and a net loss of $229.6 million; FY2025 revenue had reached $2,877.1 million, with operating income of $521.8 million and net income of $376.0 million. For the TTM through March 31, 2026, on this report's rolling basis, revenue was about $3,028.8 million, operating income about $646.5 million, net income about $479.1 million, operating cash flow about $623 million, and free cash flow about $407.4 million. The margin improvement over the past three years is real and dramatic.
| Period | Revenue | Gross margin | Operating margin | Net margin | Operating cash flow | Capex | Free cash flow |
|---|---|---|---|---|---|---|---|
| FY2021 | $1.476B | 0.1% | -16.8% | -15.6% | $250M | $101M | $150M |
| FY2022 | $1.836B | 8.2% | -1.4% | -2.7% | $6M | $91M | -$85M |
| FY2023 | $2.550B | 13.2% | 5.2% | 2.2% | $15M | $82M | -$68M |
| FY2024 | $2.760B | 21.2% | 11.7% | 6.8% | $275M | $97M | $178M |
| FY2025 | $2.877B | 26.7% | 18.1% | 13.1% | $440M | $154M | $286M |
| TTM through 2026-03 | $3.029B | 29.7% | 21.3% | 15.8% | $623M | $216M | $407M |
Table note. FY2021–FY2025 figures are company-disclosed; the TTM is rolled up from FY2025 and the nine months through March 31, 2026, and is therefore an inference. FY2021–FY2023 rely mainly on the 2023 annual report, FY2024–FY2025 mainly on the 2025 annual report, and the TTM mainly on the March 31, 2026 10-Q and earnings materials.
Three things in this table stand out most. First, the quality of the margin gains is high. FY2025 gross margin was 26.7% and operating margin 18.1%, with the TTM rising further to about 29.7% and 21.3%; and the company attributes the improvement explicitly to a higher share of high-value materials, price realization, and operating efficiency, not merely to raw-material surcharges. Second, the match between cash flow and earnings has improved significantly over the past two years: FY2024 CFO exceeded net income, as did FY2025, and CFO roughly matched net income in the first nine months of FY2026. Third, this is still a business prone to having working capital swallow cash: in the first nine months of FY2026, receivables rose $106.9 million and inventory rose $45.1 million, partly offset by a $33.6 million increase in payables, showing that growth is not free.
Turning to the balance sheet, current quality is healthy. As of March 31, 2026, the company had cash of $294.8 million, total debt of $690.4 million, shareholders' equity of $2,067.6 million, and total liabilities of $1,611.5 million; net debt was about $395.6 million. On the latest TTM EBITDA, net debt to EBITDA is roughly 0.5x; on the nine-month basis alone, operating income of $495.1 million against interest expense of $30.3 million implies interest coverage of about 16x. This means the company's danger today is not financial leverage but valuation leverage.
On returns, FY2025 ROE was about 21%, and on this report's simplified basis of after-tax operating income divided by average debt plus equity, ROIC was about 16%–17%; on the same simplified basis FY2023 ROIC was only about 5% and FY2024 rose to about 12%. That shows the company recently has not merely been "doing an accounting repair by clearing inventory" but has genuinely completed a fairly large operating re-rating. It must equally be stressed that these higher returns have not necessarily yet been tested across a full cycle.
On accounting quality, I saw no obvious signs of fraud or aggressive recognition in this research, but there are three points to keep watching. First, LIFO amplifies the impact of raw-material price changes on the income statement and gross margin. Second, surcharge revenue dilutes the headline margin, so reading GAAP gross margin alone can mislead on the operating trend. Third, PEP/Additive/distribution-related assets have seen impairments and adjustments over the past few years, indicating that the peripheral businesses still have an "expectations are realized less well than in the core" problem.
7. Owner Earnings analysis
I do not use the aggressive "net income plus all non-cash charges added back" approach, for a simple reason: stock-based compensation is not free, and this company really does spend cash on buybacks to offset dilution. So this report conservatively defines Owner Earnings as operating cash flow minus maintenance capex, and expresses it as a range rather than a single point.
| Item | Amount | Note |
|---|---|---|
| TTM net income | About $479M | Rolled up from FY2025 and the nine months of FY2026 |
| TTM depreciation and amortization | About $144M | Rolled up from FY2025 and the nine months of FY2026 |
| TTM operating cash flow | About $623M | Already reflects working-capital consumption |
| TTM total capex | About $216M | Includes brownfield expansion |
| Maintenance-capex assumption | $155M–$190M | Assumption; above or near D&A, given the intensity of melting and forging assets and FY2025 repair and maintenance expense of $128.6M |
| Conservative Owner Earnings | About $430M–$470M | Estimated as TTM CFO minus maintenance capex |
| Implied market-cap multiple | About 52x–57x | Based on the current $24.51B market cap |
Table note. The company does not separately disclose maintenance capex, so this piece is an assumption; Owner Earnings is an inference, not a GAAP metric. The underlying data come from the FY2025 annual report, the 10-Q through March 31, 2026, and the FY2025 repair-and-maintenance disclosure.
My conservative version takes the middle of the range, about $448 million of Owner Earnings. That figure is somewhat higher than current TTM free cash flow of $407 million, and the reason is not mysterious: current capex is clearly inflated by brownfield expansion, whereas Owner Earnings tries to answer the question of "how much cash the company could distribute to owners if it merely maintained its current competitive position." Even under this relatively friendly definition, the current share price corresponds to an Owner Earnings multiple of roughly 55x, which is very demanding for any capital-intensive cyclical.
So my answer to whether the profits are real cash profits or accounting profits is: over the past two years most of them are cash profits, but not the easy, reinvestment-free kind. The money this company earns now is largely real, but it still needs substantial capital to maintain and expand capacity, and during growth phases a fair amount of cash is eaten by inventory and receivables.
Valuation, Margin of Safety, and Opportunity Cost
8. Intrinsic-value estimate
Discounted owner earnings method
The valuation below is not meant to be "precise to the dollar," but to test one thing: under conservative, reasonable assumptions, is this company worth today's price? The model is based on the Owner Earnings range above; the discount rate references the current 10-year US Treasury at 4.47%, Moody's Aaa corporate bonds at 5.49%, and Baa corporate bonds at 6.01%, with a required return on equity capital of 8.5%–10%.
| Dimension | Conservative | Neutral | Optimistic |
|---|---|---|---|
| Starting Owner Earnings | $430M | $460M | $500M |
| First five-year growth | 3% | 5% | 7% |
| Second five-year growth | 2% | 3% | 4% |
| Discount rate | 10% | 9% | 8.5% |
| Terminal growth | 2% | 3% | 3% |
| Intrinsic value per share | About $113 | About $171 | About $229 |
Table note. The valuation results are this report's model estimates, not company disclosures; the input growth rates and discount rates are all assumptions. The bases come from the Owner Earnings range above and the current share count and price.
Based on this model, I offer three ranges. Conservative intrinsic value: $100–$130 per share; fair intrinsic value: $150–$190 per share; optimistic intrinsic value: $220–$260 per share. Against the current $487.25, the current price carries roughly a 156%–225% premium to the fair range; even versus the optimistic range, there is still a clear premium.
There is also an important reverse-valuation conclusion: at the current market cap, under an 8.5%–9% discount rate and 3% terminal growth, the market is roughly requiring Carpenter to raise Owner Earnings over the next decade from today's roughly $450 million to a very aggressive level, implying an Owner Earnings CAGR of about 15%–18%. For an aerospace-heavy, capital-intensive specialty-alloy manufacturer, that is not impossible, but it clearly is no longer the kind of odds that belong to "conservative value investing." This conclusion is an inference.
Relative valuation
Comparable companies are very limited. One important fact is that Carpenter itself says fewer than ten companies are its main competitors in high-value products; pure listed comparables are even fewer, with many either acquired, more diversified, or overseas. This report keeps one most representative listed comparison: ATI. I must stress: peers being expensive does not make CRS cheap.
| Metric | CRS | ATI |
|---|---|---|
| Market cap | $24.51B | $24.36B |
| P/E | 51.3x | 58.9x |
| P/B | About 11.9x | About 13.5x |
| EV/EBITDA | About 31.5x | About 29.9x |
| P/FCF | About 60.2x | About 73.0x |
| Financial leverage | Net debt/EBITDA about 0.5x | Net debt/adjusted EBITDA about 1.56x |
| Business profile | Aerospace and defense share rising, SAO margins very strong | 68% aerospace and defense in 2025, many long-term agreements |
Table note. CRS's EV/EBITDA and P/FCF are estimated here on TTM data; ATI's metrics are estimated from the latest share price, 2025 annual-report data, and a simple cash-flow basis. ATI's 2025 revenue was $4.6 billion, adjusted EBITDA $859.3 million, cash $416.7 million, total debt $1,761 million, shareholders' equity $1,804.5 million, operating cash flow $614.3 million, and capex $280.6 million.
The relative-valuation conclusion is very clear: the entire aerospace and high-end-materials chain is currently not cheap in the capital markets; CRS is not "the most outrageous of its peers," but it is certainly not "an unmeasurably cheap stock." It looks more like the market collectively paying up for "scarce aerospace and defense supply plus high materials barriers plus margin expansion." The problem is that value investing is not about judging "what the market likes most" but about judging "whether buying today offers sufficient odds." On that test, CRS still does not qualify.
Asset or liquidation value
The asset approach offers weak support for CRS. As of March 31, 2026, shareholders' equity was about $2,067.6 million, for a book value per share of about $41; stripping out goodwill and intangibles, tangible book value was about $1,835 million, or about $36.4 per share. The current price of $487.25 corresponds to about 11.9x book and more than 13x tangible book. This shows the market is not paying for the existing net assets but for a long, intense run of growth and sustained high margins. Once that expectation is disproved, asset value provides almost no floor.
Valuation conclusion. Conservative intrinsic value: $100–$130 per share. Fair intrinsic value: $150–$190 per share. Optimistic intrinsic value: $220–$260 per share. Ideal buy price: $100–$130 per share. Acceptable holding price: $130–$190 per share. Clearly overvalued: above $260 per share; the current $487.25 is clearly overvalued.
9. Margin of safety
Is the current price cheap enough? My answer is: no, and not merely "not very cheap" but "almost no margin of safety in the traditional value-investing sense." If your risk appetite is "balanced toward conservative," CRS today is more about buying growth expectations than buying a valuation discount.
The two most fragile assumptions in the valuation are these. First, whether SAO's current high margins have sufficient cross-cycle stability. Second, whether the FY2026–FY2028 acceleration in aerospace and defense demand, long-term agreements, the supply-demand gap, and the pricing environment can persist while brownfield expansion does not meaningfully dilute that scarcity. If either assumption is even slightly weaker, the current valuation will look very expensive.
If growth comes in below expectations, or margins decline, does the investment still hold? From today's starting point, it is hard to justify. The reason is not that the company would go bankrupt, but that the price you pay is too high — high enough to pre-spend most of the good news of the next decade. True "permanent loss of capital" does not necessarily come from a blowup in results; it can also come from "buying a good company at too high a price and earning only a handful of percent over ten years."
Risks, Checklist, and Final Recommendation
10. Risks and the bear case
The most important risks are not "down 5% tomorrow" but the following factors that could leave your ten-year return far below expectations, or even cause real loss of capital:
| Risk type | Specific manifestation | My view of severity |
|---|---|---|
| Cyclical risk | Swings in aerospace, defense, and energy demand and inventory cadence; output problems at key players such as Boeing affect materials cadence | High |
| Competition and substitution risk | Customers may adopt substitute materials or different manufacturing processes; the industry has high barriers but is not irreplaceable | Medium |
| Raw-material and supply-chain risk | Price and supply swings in key inputs such as nickel, cobalt, chromium, and titanium, with surcharge lag | High |
| Margin-decline risk | Current SAO high margins may partly be a cyclical windfall; the supply-demand gap narrows after expansion | High |
| Capex risk | If brownfield expansion runs over budget, is delayed, or earns below expectations, it will weigh on cash flow | Medium-high |
| Customer/end-market concentration risk | Although no single customer is concentrated, aerospace and defense are a growing share of end markets | Medium-high |
| PEP drag risk | Additive, distribution, and medical destocking keep PEP persistently weaker than SAO | Medium |
| Overvaluation risk | The current valuation is far above the range supportable by the asset and cash-flow methods | Very high |
| Accounting and comparability risk | LIFO, raw-material surcharges, and special items worsen year-over-year margin comparability | Medium |
| Interest-rate and opportunity-cost risk | The current cash yield on the stock is below the risk-free rate and high-grade bond yields | High |
Table note. The factual basis for the risk assessments comes mainly from the company's 10-K/10-Q risk and operating discussions, the current balance sheet, cash flow, and earnings guidance; "severity" is this report's opinion.
The strongest bear argument is actually very simple: you are not buying a high-end materials company the market has overlooked; you are paying up to chase an aerospace-materials winner the market already broadly recognizes. If aerospace and defense stay strong over the next few years, CRS may keep rising; but from an owner's perspective, what buying today depends on is not "market undervaluation" but "the company continuing to beat expectations, and beating them by enough to fill the current valuation premium." Those are not odds I like.
Which facts would make me admit I was wrong? If I were an empty-handed observer, the following facts would overturn my "too expensive" judgment: first, that in FY2027–FY2028 the company lifts Owner Earnings toward $800 million–$1,000 million and sustains it without materially adding leverage; second, that after brownfield expansion completes, the supply-demand gap does not converge and SAO's high margins hold; third, that the share price stays flat while the company grows into the valuation. Conversely, if I already held it, the following facts would overturn my "company quality is improving" judgment: SAO margins declining steadily, long-term agreements no longer providing price stability, aerospace structural orders slowing from double-digit growth, and working capital eating most of the cash flow over the long run.
The largest permanent-capital-loss scenario is not bankruptcy but the more common and more realistic one: a cyclical downturn plus mean reversion in margins plus multiple compression happening at once. In that case you could be left holding a still-decent company that corresponds to a far lower fair valuation than today's.
11. Comparison with other opportunities
Compared with its strongest peer ATI, CRS has no clear valuation-cheapness advantage; both sit in a high-valuation zone. ATI has a higher aerospace and defense share and greater scale, but the market assigns it a very high multiple too. That shows buying CRS is not exploiting a mispriced peer but participating in the sector's overall heat.
Compared with a broad index, I do not think CRS at the current price is clearly superior to buying the index. The reason is not that the company's quality is poor, but that its return distribution depends more on a single industry cycle and on margins holding, whereas an S&P 500 ETF at least gives you diversification. Against the 10-year US Treasury at 4.47%, Moody's Aaa at 5.49%, and Baa at 6.01%, CRS's current TTM free-cash-flow yield is only about 1.7%, and even its conservative Owner Earnings yield is only about 1.8%; only if you believe it will reinvest at high rates and sustain high returns over a very long time can this stock outperform bonds and the index at today's price.
If I could hold only five assets, my answer is: at the current price, it does not qualify for the portfolio. For one reason only: the odds are not good enough.
12. Investment checklist
| Checklist question | Conclusion |
|---|---|
| Can I understand this business? | Pass |
| Does it have stable long-term demand? | Pass |
| Does it have a durable moat? | Pass, but not especially wide |
| Does it have pricing power? | Partial pass |
| Can it produce stable free cash flow? | Uncertain |
| Are its returns on capital excellent? | Currently yes, pass; cross-cycle still to be proven |
| Is management trustworthy? | Pass |
| Is capital allocation rational? | Pass |
| Is the balance sheet sound? | Pass |
| Is the valuation below intrinsic value? | Fail |
| Is the margin of safety sufficient? | Fail |
| Does long-term ownership let me sleep easy? | Pass on the business, fail on the price |
| Which key facts would make me sell or reassess? | SAO margins and aerospace orders weakening, cash flow chronically swallowed by working capital, expansion returns below expectations |
| Am I tempted to buy only because the stock has risen or because of market sentiment? | This is especially worth guarding against right now |
13. Final investment conclusion
【Final Rating】 Watch
【One-line investment thesis】 Carpenter Technology is a high-end specialty-materials company whose operating quality has clearly upgraded, but at the current price the market has already bought in too much future growth and peak margins.
【Core bull case】 First, aerospace and defense are a rising share, and the business mix is improving. Second, SAO's certification barriers, process capabilities, and customer-qualification system are real. Third, cash flow, margins, and the balance sheet have improved markedly over the past two years. Fourth, management's capital allocation in recent years is more rational than in the past, with low leverage, a steady dividend, buybacks at lower prices, and advancing expansion. Fifth, if aerospace and defense conditions persist, the company retains the ability to keep releasing profit.
【Core bear case】 First, the current valuation is extremely high and lacks a margin of safety. Second, this is still a capital-intensive, highly cyclical business, not a super consumer brand that rides through the cycle. Third, the current high margins may partly come from favorable conditions and the supply-demand gap, and may not be fully structural. Fourth, PEP/Additive is still a drag, indicating the company's quality is uneven. Fifth, the current cash yield is clearly below risk-free and high-grade bond yields, so the opportunity cost is high.
【Key assumptions】 For the investment to hold, the following must be true: aerospace and defense demand keeps growing; SAO's high margins are broadly sustained; brownfield expansion lands on schedule and on budget with adequate returns; working capital does not permanently swallow most of the cash flow; and the company does not destroy per-share value through expensive acquisitions or buybacks at high valuations.
【Fair buy price】 The range I give is $100–$130 per share. The basis is that this range is close to this report's conservative intrinsic-value range and leaves enough room for cyclical and execution risk. If you require a wider margin of safety, you should wait for an even lower price.
【Target holding period】 More than 10 years, but only on the condition of buying at a reasonable price. If you buy at too high a valuation, even a long enough holding period will not automatically fix the return problem.
【Expected annualized return】 Buying at the current roughly $487.25 and holding for ten years, my scenario estimate is: about -7% per year conservative, about -2% per year neutral, and about +2% per year optimistic. These numbers do not assume the fundamentals collapse; they reflect that the starting valuation is too high, so most future returns must come from the company continuing to beat expectations to "grow into the valuation." This is this report's model inference.
【Maximum loss risk】 If industry conditions cool, margins mean-revert, and the multiple falls back to a more normal industrial-stock range, the share price could see a sharp drawdown. Given the relationship between valuation and asset support, a drawdown of more than 50% in the worst case is not hard to imagine; layer in a cyclical trough and it could be deeper. This is not bankruptcy risk but the typical consequence of buying at a high valuation.
【Tracking indicators】 The indicators most worth tracking going forward are: aerospace and defense sales growth excluding surcharges and the double-digit trend in structural orders; SAO's adjusted operating margin; whether PEP's margins and Additive's improvement are sustainable; FY2026–FY2028 adjusted free cash flow and the capex cadence; turnover in inventory, receivables, and payables; net debt to EBITDA; buyback amounts, share counts, and average prices; the build-rate cadence at Boeing and engine customers; whether medical destocking has ended; and the progress and return on investment of the brownfield project.
【Signals that trigger reassessment】 If any of the following occurs, the investment logic must be re-examined: SAO margins declining clearly for several consecutive quarters; the double-digit momentum in aerospace structural orders disappearing; free cash flow not stepping up with expansion after FY2027; inventory and receivables persistently growing faster than revenue; management beginning to make expensive acquisitions or large buybacks at very high valuations; and continued PEP weakness eroding the group's valuation story.
【Final recommendation】 Coolly put, CRS is admirable, but not worth rushing to own at today's price. Put it on the watch list and keep tracking core-business margins, expansion returns, and cash-flow quality; if a significant pullback comes in the future without the fundamentals being damaged, it is more likely to turn from an "excellent company" into an "excellent investment."
Open questions and limitations. First, management does not separately disclose "maintenance capex," so Owner Earnings and the DCF can only be range estimates. Second, the number of pure listed comparables is limited, so the reference sample for industry relative valuation is inherently small. Third, the complete management-ownership table in the latest proxy statement could not be fully extracted in this research, so the judgment on "whether ownership is large enough" can only reach a cautiously neutral conclusion.
This report is based on public information and does not constitute investment advice. Markets carry risk; invest with caution.
Full report
Sign in to read the full report
Sign up free to unlock the full text, the Baillie growth scorecard, and full-text search.
Log in / Sign up free